{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:46:15Z","timestamp":1785923175537,"version":"3.56.0"},"reference-count":29,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>Background and Clinical Significance: Metaplastic breast carcinoma (MBC) is a rare type of breast tumor with various subtypes. MBCs are typically high-grade and exhibit a particularly aggressive behavior, with a significant propensity for recurrence and specific chemoresistance, especially in neoadjuvant settings. One of its high-grade variants is the metaplastic carcinoma with heterologous mesenchymal differentiation (MCHMD). At present, the literature regarding the genetic predisposition of MBC and its connection with BRCA2 is limited. Hence, we present a rare case of a 51-year-old patient with a germline BRCA2 pathogenic variant affected by MCHMD. Case presentation: A 51-year-old Caucasian woman with a family history of breast cancer noticed a lump in her right breast. A needle biopsy of the mass resulted in a diagnosis of poorly differentiated (G3) invasive ductal carcinoma, associated with a dominant component of pleomorphic carcinoma with osteoclast-like cells. After surgery, the pathological report diagnosed a metaplastic carcinoma of the breast with heterologous mesenchymal differentiation (MCHMD) according to the WHO 2019 classification. Genetic testing revealed the presence of the pathogenic variant c.9676del of the BRCA2 gene. Conclusions: We report, to the best of our knowledge, the first case of a BRCA2 mutation in a woman with metaplastic carcinoma of the breast with heterologous mesenchymal differentiation.<\/jats:p>","DOI":"10.3390\/reports9030255","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:14:46Z","timestamp":1785917686000},"page":"255","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Germline BRCA2 Pathogenic Variant in Metaplastic Breast Carcinoma with Heterologous Mesenchymal Differentiation: A Case Report and Literature Review"],"prefix":"10.3390","volume":"9","author":[{"given":"Alice","family":"Arduini","sequence":"first","affiliation":[{"name":"Section of Pathology, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Polati","sequence":"additional","affiliation":[{"name":"Section of Pathology, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2485-7557","authenticated-orcid":false,"given":"Giulio Luigi","family":"Bonisoli","sequence":"additional","affiliation":[{"name":"Section of Internal Medicine B, Department of Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3700-6989","authenticated-orcid":false,"given":"Sokol","family":"Sina","sequence":"additional","affiliation":[{"name":"Section of Pathology, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13058-020-01353-z","article-title":"A comprehensive overview of metaplastic breast cancer: Clinical features and molecular aberrations","volume":"22","author":"Reddy","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.4103\/jcrt.jcrt_1517_21","article-title":"Metaplastic breast carcinoma with mesenchymal differentiation: Acase series","volume":"19","author":"Rani","year":"2023","journal-title":"J. Cancer Res. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.32074\/1591-951X-1-20","article-title":"Histological type and typing of breast carcinomas and the WHO classification changes over time","volume":"112","author":"Cserni","year":"2020","journal-title":"Pathologica"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10549-023-06945-9","article-title":"The mixed subtype has a worse prognosis than other histological subtypes: A retrospective analysis of 217 patients with metaplastic breast cancer","volume":"200","author":"Hu","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clbc.2017.04.009","article-title":"Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature","volume":"17","author":"Hughes","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3349\/ymj.2010.51.6.864","article-title":"Clinicopathologic Features and Outcomes of Metaplastic Breast Carcinoma: Comparison with Invasive Ductal Carcinoma of the Breast","volume":"51","author":"Park","year":"2010","journal-title":"Yonsei Med. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jso.26248","article-title":"Metaplastic breast cancer: Prognostic and therapeutic considerations","volume":"123","author":"Corso","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/his.14808","article-title":"Hereditary breast cancer: Syndromes, tumour pathology and molecular testing","volume":"82","author":"Sokolova","year":"2023","journal-title":"Histopathology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41431-023-01429-2","article-title":"Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene","volume":"31","author":"Corso","year":"2023","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/BD-170313","article-title":"Metaplastic carcinoma of the breast with mesenchymal differentiation (carcinosarcoma). A unique presentation of an aggressive malignancy and literature review","volume":"37","author":"Salemis","year":"2018","journal-title":"Breast Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12998\/wjcc.v11.i7.1521","article-title":"Invasive breast carcinoma with osteoclast-like stromal giant cells: A case report","volume":"11","author":"Wang","year":"2023","journal-title":"World J. Clin. Cases"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/modpathol.2014.142","article-title":"Metastatic breast carcinomas display genomic and transcriptomic heterogeneity","volume":"28","author":"Weigelt","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000101515","article-title":"BRCA1 Germline Mutation in a Woman with Metaplastic Squamous Cell Breast Cancer","volume":"30","author":"Breuer","year":"2007","journal-title":"Oncol. Res. Treat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12282-009-0105-0","article-title":"Mixed epithelial\/mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast in BRCA1 carrier","volume":"18","author":"Suspitsin","year":"2011","journal-title":"Breast Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.prp.2010.01.008","article-title":"Low-grade adenosquamous carcinoma of the breast\u2014A case report with a BRCA1 germline mutation","volume":"206","author":"Buxant","year":"2010","journal-title":"Pathol.-Res. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.prp.2011.05.011","article-title":"A deleterious BRCA1 mutation in a young Pakistani woman with metaplastic breast carcinoma","volume":"207","author":"Rashid","year":"2011","journal-title":"Pathol.-Res. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10549-014-3011-x","article-title":"Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer","volume":"146","author":"Bell","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.clbc.2016.08.002","article-title":"Carcinosarcoma of the Breast: An Aggressive Subtype of Metaplastic Cancer. Report of a Rare Case in a Young BRCA-1 Mutated Woman","volume":"17","author":"Ghilli","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13053-020-00162-x","article-title":"Metaplastic carcinoma of the breast and BRCA1 germline mutation: A case report and review","volume":"19","author":"Yamashita","year":"2021","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"107513","DOI":"10.1016\/j.ijscr.2022.107513","article-title":"Breast cancer in a teenage girl with BRCA mutation: A case report from a low middle-income country","volume":"98","author":"Vohra","year":"2022","journal-title":"Int. J. Surg. Case Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/1878-0261.12813","article-title":"The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas","volume":"15","author":"Moukarzel","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nature03404","article-title":"CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair","volume":"434","author":"Esashi","year":"2005","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1038\/onc.2008.17","article-title":"The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage","volume":"27","author":"Bahassi","year":"2008","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"E1200","DOI":"10.1002\/humu.21202","article-title":"Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: The WECARE study","volume":"31","author":"Borg","year":"2010","journal-title":"Hum. Mutat."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: Different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Santonocito, C., Rizza, R., Paris, I., De Marchis, L., Paolillo, C., Tiberi, G., Scambia, G., and Capoluongo, E. (2020). Spectrum of germline BRCA1 and BRCA2 variants identified in 2351 ovarian and breast cancer patients referring to a reference cancer hospital of Rome. Cancers, 12.","DOI":"10.3390\/cancers12051286"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/humu.23406","article-title":"Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations","volume":"39","author":"Rebbeck","year":"2018","journal-title":"Hum. Mutat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/gcc.22383","article-title":"BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report","volume":"55","author":"Pilato","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.5858\/arpa.2019-0396-RA","article-title":"Metaplastic Breast Carcinoma: Update on Histopathology and Molecular Alterations","volume":"143","author":"McMullen","year":"2019","journal-title":"Arch. Pathol. Lab. Med."}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/3\/255\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:09:03Z","timestamp":1785920943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/3\/255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["reports9030255"],"URL":"https:\/\/doi.org\/10.3390\/reports9030255","relation":{},"ISSN":["2571-841X"],"issn-type":[{"value":"2571-841X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}